PHARMACY

NCPA applauds CMS’ decision to allow indie pharmacies to provide diabetes testing supplies

BY Allison Cerra

ALEXANDRIA, Va. The Centers for Medicare and Medicaid Services’ proposed legislation that would exempt owner-operated pharmacies from Medicare Part B recoupment efforts is drawing praise from the industry.

The National Community Pharmacists Association stated on Tuesday that exempting community pharmacies from the upcoming bidding process for Medicare Part B diabetes testing supplies, along with instructions that exempt most independent community pharmacies from accreditation requirements, “are wide-ranging and have significant implications for pharmacies.”

Community pharmacies tend to be hit the hardest when it comes to recoupment activities, since the indie businesses cannot sustain with costs that only large chains can handle without sacrificing their entire business.

Acting EVP and CEO Douglas Hoey said, “Community pharmacists can be tremendous assets in the fight against diabetes. … NCPA will continue reviewing both proposals carefully and will respond more formally to the proposed regulation during the comment period. We look forward to continuing to work with CMS officials to ensure that community pharmacists can continue to play a vital role in helping Medicare’s diabetes patients maximize their health while controlling costs.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

Former Johnson & Johnson head dies at 94

BY Allison Cerra

NEW BRUNSWICK, N.J. A former leader of one of the largest health conglomerates in the world died Friday at 94.

Richard Sellars rose from junior salesman to chairman of the board and CEO during a career that spanned 40 years at Johnson & Johnson. Sellars joined Johnson & Johnson’s sales force in 1939, and began a rapid rise within two of the company’s major affiliates, Ortho Pharmaceutical Corp. and Ethicon. He became president of the company in 1970, and chairman of the board one year later. In 1973, he became chairman and CEO, a position he held until his retirement from that post in 1976. From then until his retirement in 1979, Sellars served as chairman of Johnson & Johnson’s finance committee. One of his many accomplishments while at Johnson & Johnson was being part of the New Brunswick Tomorrow project to revitalize the city that held the company’s headquarters.

“Richard Sellars was an inspirational leader who filled all who met him with a deep sense of the company’s responsibility to its customers, employees, community and shareholders,” said William Weldon, chairman and CEO, Johnson & Johnson. “He will be missed.”

Sellars is survived by his wife, Doris, four children, nine grandchildren and 13 great-grandchildren.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

Gilead to acquire CGI

BY Alaric DeArment

FOSTER CITY, Calif. Gilead Sciences plans to acquire a development-stage pharmaceutical company for up to $120 million, Gilead said Friday.

Privately held CGI Pharmaceuticals has developed a library of drugs that have potential to treat inflammatory diseases such as rheumatoid arthritis. The majority of the $120 million will be an upfront payment, and the remaining will be based on clinical development progress, Gilead said.

“The acquisition of CGI represents a unique opportunity to expand our research efforts in an interesting and promising area of drug discovery,” Gilead EVP research and development and chief scientific officer Norbert Bischofberger said.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES